These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 27865894)

  • 41. Peroxisome proliferator-activated receptor-γ (PPAR-γ) agonist inhibits collagen synthesis in human hypertrophic scar fibroblasts by targeting Smad3 via miR-145.
    Zhu HY; Li C; Zheng Z; Zhou Q; Guan H; Su LL; Han JT; Zhu XX; Wang SY; Li J; Hu DH
    Biochem Biophys Res Commun; 2015 Mar; 459(1):49-53. PubMed ID: 25704091
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protective effect of peroxisome proliferator-activated receptor-gamma agonists on activated renal proximal tubular epithelial cells in IgA nephropathy.
    Xiao J; Leung JC; Chan LY; Guo H; Lai KN
    Nephrol Dial Transplant; 2009 Jul; 24(7):2067-77. PubMed ID: 19155534
    [TBL] [Abstract][Full Text] [Related]  

  • 43. STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer.
    Iliopoulos D; Jaeger SA; Hirsch HA; Bulyk ML; Struhl K
    Mol Cell; 2010 Aug; 39(4):493-506. PubMed ID: 20797623
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thiazolidinediones/PPARγ agonists and fatty acid synthase inhibitors as an experimental combination therapy for prostate cancer.
    Mansour M; Schwartz D; Judd R; Akingbemi B; Braden T; Morrison E; Dennis J; Bartol F; Hazi A; Napier I; Abdel-Mageed AB
    Int J Oncol; 2011 Feb; 38(2):537-46. PubMed ID: 21170507
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo.
    Yu J; Qiao L; Zimmermann L; Ebert MP; Zhang H; Lin W; Röcken C; Malfertheiner P; Farrell GC
    Hepatology; 2006 Jan; 43(1):134-43. PubMed ID: 16374840
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Peroxisome proliferator-activated receptor-gamma agonists inhibit respiratory syncytial virus-induced expression of intercellular adhesion molecule-1 in human lung epithelial cells.
    Arnold R; Neumann M; König W
    Immunology; 2007 May; 121(1):71-81. PubMed ID: 17425601
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PPARgamma agonists upregulate the barrier function of tight junctions via a PKC pathway in human nasal epithelial cells.
    Ogasawara N; Kojima T; Go M; Ohkuni T; Koizumi J; Kamekura R; Masaki T; Murata M; Tanaka S; Fuchimoto J; Himi T; Sawada N
    Pharmacol Res; 2010 Jun; 61(6):489-98. PubMed ID: 20227502
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thiazolidinedione, a peroxisome proliferator-activated receptor-gamma ligand, inhibits growth and metastasis of HT-29 human colon cancer cells through differentiation-promoting effects.
    Yoshizumi T; Ohta T; Ninomiya I; Terada I; Fushida S; Fujimura T; Nishimura G; Shimizu K; Yi S; Miwa K
    Int J Oncol; 2004 Sep; 25(3):631-9. PubMed ID: 15289864
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sepsis-induced inhibition of neutrophil chemotaxis is mediated by activation of peroxisome proliferator-activated receptor-{gamma}.
    Reddy RC; Narala VR; Keshamouni VG; Milam JE; Newstead MW; Standiford TJ
    Blood; 2008 Nov; 112(10):4250-8. PubMed ID: 18535203
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Peroxisome proliferator-activated receptor-gamma inhibits cigarette smoke solution-induced mucin production in human airway epithelial (NCI-H292) cells.
    Lee SY; Kang EJ; Hur GY; Jung KH; Jung HC; Lee SY; Kim JH; Shin C; In KH; Kang KH; Yoo SH; Shim JJ
    Am J Physiol Lung Cell Mol Physiol; 2006 Jul; 291(1):L84-90. PubMed ID: 16443643
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rosiglitazone sensitizes MDA-MB-231 breast cancer cells to anti-tumour effects of tumour necrosis factor-alpha, CH11 and CYC202.
    Mody M; Dharker N; Bloomston M; Wang PS; Chou FS; Glickman TS; McCaffrey T; Yang Z; Pumfery A; Lee D; Ringel MD; Pinzone JJ
    Endocr Relat Cancer; 2007 Jun; 14(2):305-15. PubMed ID: 17639046
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vivo and in vitro regulation of syndecan 1 in prostate cells by n-3 polyunsaturated fatty acids.
    Edwards IJ; Sun H; Hu Y; Berquin IM; O'Flaherty JT; Cline JM; Rudel LL; Chen YQ
    J Biol Chem; 2008 Jun; 283(26):18441-9. PubMed ID: 18450755
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Klotho is a target gene of PPAR-gamma.
    Zhang H; Li Y; Fan Y; Wu J; Zhao B; Guan Y; Chien S; Wang N
    Kidney Int; 2008 Sep; 74(6):732-9. PubMed ID: 18547997
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Growth arrest by troglitazone is mediated by p27Kip1 accumulation, which results from dual inhibition of proteasome activity and Skp2 expression in human hepatocellular carcinoma cells.
    Motomura W; Takahashi N; Nagamine M; Sawamukai M; Tanno S; Kohgo Y; Okumura T
    Int J Cancer; 2004 Jan; 108(1):41-6. PubMed ID: 14618613
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effects of peroxisome proliferator-activated receptor-gamma ligand troglitazone on colon cancer cell growth].
    Koirala K; Wan YL; Liu YC; Wang X; Cui W; Wang CL; Chen HN; Wang HY; Zhu J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Aug; 38(4):385-8. PubMed ID: 16892143
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypoxia reduces the expression and anti-inflammatory effects of peroxisome proliferator-activated receptor-gamma in human proximal renal tubular cells.
    Li X; Kimura H; Hirota K; Sugimoto H; Kimura N; Takahashi N; Fujii H; Yoshida H
    Nephrol Dial Transplant; 2007 Apr; 22(4):1041-51. PubMed ID: 17255125
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The protective effects and mechanisms of peroxisome proliferator-activated receptor-gamma agonist in rats with acute lung injury].
    Wang JC; Jiang P; Huang J; Qian GS
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Jun; 31(6):425-30. PubMed ID: 19031802
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proinflammatory stimulation and pioglitazone treatment regulate peroxisome proliferator-activated receptor gamma levels in peripheral blood mononuclear cells from healthy controls and multiple sclerosis patients.
    Klotz L; Schmidt M; Giese T; Sastre M; Knolle P; Klockgether T; Heneka MT
    J Immunol; 2005 Oct; 175(8):4948-55. PubMed ID: 16210596
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential effects of peroxisome proliferator activated receptor-gamma (PPAR gamma) ligands in proximal tubular cells: thiazolidinediones are partial PPAR gamma agonists.
    Chana RS; Lewington AJ; Brunskill NJ
    Kidney Int; 2004 Jun; 65(6):2081-90. PubMed ID: 15149321
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activation of peroxisome proliferator-activated receptor-gamma protects pancreatic beta-cells from cytokine-induced cytotoxicity via NF kappaB pathway.
    Kim EK; Kwon KB; Koo BS; Han MJ; Song MY; Song EK; Han MK; Park JW; Ryu DG; Park BH
    Int J Biochem Cell Biol; 2007; 39(6):1260-75. PubMed ID: 17521952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.